Publications by authors named "Yuuri Hashimoto"

Claim this Profile
C
Chromosomal Instability Is Associated with cGAS-STING Activation in EGFR-TKI Refractory Non-Small-Cell Lung Cancer.
Kimio Yonesaka, Takashi Kurosaki, Junko Tanizaki, Hisato Kawakami, Kaoru Tanaka, Yuuri Hashimoto

Cells· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Adenovirus E1A Reverses Transforming Growth Factor-β-induced Epithelial-mesenchymal Transition in Human Esophageal Cancer Cells.
Tomoya Masuda, Hiroshi Tazawa, Yuuri Hashimoto, Takeshi Ieda, Satoru Kikuchi

Acta Med Okayama· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer.
Kimio Yonesaka, Junko Tanizaki, Osamu Maenishi, Koji Haratani, Hisato Kawakami, Yuuri Hashimoto

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.
Martina Ott, Cynthia Kassab, Anantha Marisetty, Yuuri Hashimoto, Jun Wei

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.
Shinichiro Watanabe, Kazuhiro Noma, Toshiaki Ohara, Hajime Kashima, Hiroaki Sato, Yuuri Hashimoto

Cancer Biol Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization.
Yuuri Hashimoto, Kumiko Koyama, Yasuki Kamai, Kenji Hirotani, Yusuke Ogitani

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
Jun Wei, Anantha Marisetty, Brett Schrand, Konrad Gabrusiewicz, Yuuri Hashimoto

J Clin Invest· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer.
Megumi Watanabe, Shunsuke Kagawa, Kazuya Kuwada, Yuuri Hashimoto, Kunitoshi Shigeyasu

Cancer Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
Richard G Everson, Yuuri Hashimoto, Jacob L Freeman, Tiffany R Hodges, Jason Huse

J Neurooncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking medulloblastoma from a targeted therapeutics perspective.
Yuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, Jun Wei, Soumen Khatua

J Neurooncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ependymomas overexpress chemoresistance and DNA repair-related proteins.
Sherise D Ferguson, Shouhao Zhou, Joanne Xiu, Yuuri Hashimoto, Nader Sanai

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
Konrad Gabrusiewicz, Xu Li, Jun Wei, Yuuri Hashimoto, Anantha L Marisetty

Oncoimmunology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulatory nanoparticle therapeutics for intracerebral glioma.
Nasser K Yaghi, Jun Wei, Yuuri Hashimoto, Ling-Yuan Kong, Konrad Gabrusiewicz

Neuro Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-specific delivery of biologics by a novel T-cell line HOZOT.
Teppei Onishi, Hiroshi Tazawa, Yuuri Hashimoto, Makoto Takeuchi, Takeshi Otani

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.
Sarah T Garber, Yuuri Hashimoto, Shiao-Pei Weathers, Joanne Xiu, Zoran Gatalica

Neuro Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.
Yong Qin, Jason Roszik, Chandrani Chattopadhyay, Yuuri Hashimoto, Chengwen Liu

Mol Cancer Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.
Jun Wei, Edjah K Nduom, Ling-Yuan Kong, Yuuri Hashimoto, Shuo Xu

Neuro Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsomal PGE2 synthase-1 regulates melanoma cell survival and associates with melanoma disease progression.
Sun-Hee Kim, Yuuri Hashimoto, Sung-Nam Cho, Jason Roszik, Denái R Milton

Pigment Cell Melanoma Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Konrad Gabrusiewicz, Benjamin Rodriguez, Jun Wei, Yuuri Hashimoto, Luke M Healy

JCI Insight· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Kiyoto Takehara, Hiroshi Tazawa, Naohiro Okada, Yuuri Hashimoto, Satoru Kikuchi

Mol Cancer Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.
Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe Samaniego

J Invest Dermatol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.
Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe Samaniego

J Invest Dermatol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics.
Kunitoshi Shigeyasu, Hiroshi Tazawa, Yuuri Hashimoto, Yoshiko Mori, Masahiko Nishizaki

Gut· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological ablation of sentinel lymph node metastasis in submucosally invaded early gastrointestinal cancer.
Satoru Kikuchi, Hiroyuki Kishimoto, Hiroshi Tazawa, Yuuri Hashimoto, Shinji Kuroda

Mol Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells.
Kyoko Shimoyama, Shunsuke Kagawa, Michihiro Ishida, Shinichiro Watanabe, Kazuhiro Noma, Yuuri Hashimoto

Breast Cancer Res Treat· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis